Comparison of Vascular Function in Emergency Service Professionals
FIRECOP
2 other identifiers
observational
36
1 country
1
Brief Summary
Emergency Service Professionals have an increased risk of death from heart attacks when compared to the general public. All the emergency professions share similar responsibilities such as emergency call-outs and shift work. Heart disease is the commonest cause of on-duty death amongst fire-fighters accounting for 45% and compared with 22% in police officers and 15% in the general population. The unique risk to fire-fighters is likely to reflect a combination of factors including extreme physical exertion, mental stress, heat and pollutant exposure. In this study the investigators will assess healthy career fire-fighters and age-matched healthy police officer control subjects following a sedentary period. The investigators will take blood samples to measure platelet activity (platelets are the particles in blood that help blood clot) and will examine how blood clots outside of the body. The investigators will then perform studies placing small needles in the arm to assess how the blood vessels respond following these duties. The investigators hypothesise that fire-fighters do not have pre-existing impairment of heart, blood or blood vessel function as a cumulative effect of their occupation, but rather these are acute and transitory effects following distinct fire-fighter duties. We therefore expect similar results in both occupational groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 14, 2013
CompletedFirst Posted
Study publicly available on registry
March 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedMay 3, 2024
March 1, 2013
1 year
March 14, 2013
May 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Forearm blood flow measured by venous occlusion plethysmography in response to infused vasodilators
following 48 hours off duty
Secondary Outcomes (2)
Ex-vivo thrombus formation using the Badimon chamber
following 48 hours off duty
Plasma t-PA and PAI concentrations following infusion of bradykinin
During forearm study, following 48 hours off duty
Study Arms (2)
Firefighters
20 firefighters will attend for vascular assessments following a minimum of 48 hours off-duty.
Police Officers
20 police officers will attend for vascular assessments following a minimum of 48 hours off-duty.
Interventions
Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).
Ex-vivo assessment of thrombus formation using the Badimon Chamber
Eligibility Criteria
Subjects will be healthy, non-smoking, whole-time firefighters working within Lothian and Borders Fire and Rescue Service and age- and sex-matched police officers who are also healthy and non-smokers working within Lothian and Borders Police Force.
You may qualify if:
- Non-smoking healthy firefighters
You may not qualify if:
- Current smoker
- History of lung or ischaemic heart disease
- Malignant arrhythmia
- Systolic blood pressure \>190mmHg or \<100mmHg
- Renal or hepatic dysfunction
- Previous history of blood dyscrasia
- Unable to tolerate the supine position
- Blood donation within the last 3 months
- Recent respiratory tract infection within the past 4 weeks
- Routine medication including aspirin and NSAIDs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Infirmary of Edinburgh Clinical Research Facility
Edinburgh, EH16 4SA, United Kingdom
Biospecimen
Plasma and urine.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
David E Newby, MD PhD
University of Edinburgh
- STUDY DIRECTOR
Nicholas L Mills, MBChB PhD
University of Edinburgh
- PRINCIPAL INVESTIGATOR
Amanda L Hunter, MBChB
University of Edinburgh
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2013
First Posted
March 18, 2013
Study Start
April 1, 2012
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
May 3, 2024
Record last verified: 2013-03